Cargando…

CD30(+) lymphomatoid skin toxicity secondary to ipilimumab

Detalles Bibliográficos
Autores principales: Bush, Amelia E., Garcia, Andres, Li, Janet, Curry, Jonathan, Chon, Susan Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082605/
https://www.ncbi.nlm.nih.gov/pubmed/32211493
http://dx.doi.org/10.1016/j.jdcr.2016.07.008
_version_ 1783508379025539072
author Bush, Amelia E.
Garcia, Andres
Li, Janet
Curry, Jonathan
Chon, Susan Y.
author_facet Bush, Amelia E.
Garcia, Andres
Li, Janet
Curry, Jonathan
Chon, Susan Y.
author_sort Bush, Amelia E.
collection PubMed
description
format Online
Article
Text
id pubmed-7082605
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-70826052020-03-24 CD30(+) lymphomatoid skin toxicity secondary to ipilimumab Bush, Amelia E. Garcia, Andres Li, Janet Curry, Jonathan Chon, Susan Y. JAAD Case Rep Case Report Elsevier 2020-03-19 /pmc/articles/PMC7082605/ /pubmed/32211493 http://dx.doi.org/10.1016/j.jdcr.2016.07.008 Text en © 2016 Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Bush, Amelia E.
Garcia, Andres
Li, Janet
Curry, Jonathan
Chon, Susan Y.
CD30(+) lymphomatoid skin toxicity secondary to ipilimumab
title CD30(+) lymphomatoid skin toxicity secondary to ipilimumab
title_full CD30(+) lymphomatoid skin toxicity secondary to ipilimumab
title_fullStr CD30(+) lymphomatoid skin toxicity secondary to ipilimumab
title_full_unstemmed CD30(+) lymphomatoid skin toxicity secondary to ipilimumab
title_short CD30(+) lymphomatoid skin toxicity secondary to ipilimumab
title_sort cd30(+) lymphomatoid skin toxicity secondary to ipilimumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082605/
https://www.ncbi.nlm.nih.gov/pubmed/32211493
http://dx.doi.org/10.1016/j.jdcr.2016.07.008
work_keys_str_mv AT bushameliae cd30lymphomatoidskintoxicitysecondarytoipilimumab
AT garciaandres cd30lymphomatoidskintoxicitysecondarytoipilimumab
AT lijanet cd30lymphomatoidskintoxicitysecondarytoipilimumab
AT curryjonathan cd30lymphomatoidskintoxicitysecondarytoipilimumab
AT chonsusany cd30lymphomatoidskintoxicitysecondarytoipilimumab